Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Late effects, long‐term problems and unmet needs of cancer survivors
Martina E. Schmidt, Siri Goldschmidt, Silke Hermann, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 8, pp. 1280-1290
Open Access | Times Cited: 60
Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment
Raymond J. Chan, Adam K. Walker, Janette Vardy, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 4
Open Access | Times Cited: 1
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
Yang Yang, Bing Zhao, Xuejiao Gao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 52
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction
Claudia Cristiano, Mariarosaria Cuozzo, Lorena Coretti, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113528-113528
Closed Access | Times Cited: 32
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 8
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
Guido Cavaletti, P Marmiroli
Cancers (2020) Vol. 12, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 49
The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis
Jiahui Luo, Ruiqi Liu, Yuanyuan Luo, et al.
Asia-Pacific Journal of Oncology Nursing (2023) Vol. 10, Iss. 4, pp. 100200-100200
Open Access | Times Cited: 15
Neurological Complications of Conventional and Novel Anticancer Treatments
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6088-6088
Open Access | Times Cited: 22
Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels
Lulian Pang, Wen Li, Senbang Yao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11806-11815
Open Access | Times Cited: 11
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors
Kazuya Saita, S. Amano, Fumiko Kaneko, et al.
Frontiers in Human Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Prevalence of pre-existing cognitive impairment in patients treated for cancer and the impact of cancer treatment on cognitive outcomes: A scoping review
Nelly Toledano, Valentina Donison, Avital Sigal, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 4, pp. 102235-102235
Closed Access
Cancer
Rachael L. Ellison, Hannah B. VanLandingham, Joyce W. Tam, et al.
(2025), pp. 235-261
Closed Access
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 21
Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models
Ana Bagüés, Yolanda López‐Tofiño, Alvaro Llorente‐Berzal, et al.
Behavioural Pharmacology (2022) Vol. 33, Iss. 2&3, pp. 105-129
Closed Access | Times Cited: 15
Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers
Myrthe Mampay, Melanie S. Flint, Graham K. Sheridan
British Journal of Pharmacology (2021) Vol. 178, Iss. 19, pp. 3977-3996
Open Access | Times Cited: 19
Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: A systematic review
Laura Oldacres, Josephine Hegarty, Patricia O’Regan, et al.
Psycho-Oncology (2022) Vol. 32, Iss. 2, pp. 214-228
Open Access | Times Cited: 13
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
Annemarie C. Eggen, Nadine Richard, Ingeborg Bosma, et al.
Neuro-Oncology Practice (2021) Vol. 9, Iss. 1, pp. 50-58
Open Access | Times Cited: 18
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer
Valentina Elisabetta Di Mattei, Gaia Perego, Paola Taranto, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 9, pp. 7333-7339
Open Access | Times Cited: 12
Methotrexate Neurotoxicity Is Related to Epigenetic Modification of the Myelination Process
Yu‐Chieh Chen, Jiunn‐Ming Sheen, Su‐Chen Wang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6718-6718
Open Access | Times Cited: 15
Cancer‐related cognitive impairment in survivors of adolescent and young adult non‐central nervous system cancer: A scoping review
Lisa M. Vizer, Sean P. Mikles, Aaron T. Piepmeier
Psycho-Oncology (2022) Vol. 31, Iss. 8, pp. 1275-1285
Closed Access | Times Cited: 11
The Anti-Inflammatory Drug Aspirin Does Not Protect Against Chemotherapy-Induced Memory Impairment by Paclitaxel in Mice
Aeson Chang, Ni-Chun Chung, Adam J. Lawther, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 15
Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints
Kete M. Klaver, Saskia F. A. Duijts, Chantal Geusgens, et al.
Journal of Cancer Survivorship (2022) Vol. 18, Iss. 2, pp. 412-424
Closed Access | Times Cited: 9
The Fast Cognitive Evaluation (FaCE): a screening tool to detect cognitive impairment in patients with cancer
Amel Baghdadli, Giovanni G. Arcuri, Clarence G. Green, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Effect of mHealth plus occupational therapy on cognitive function, mood and physical function in people after cancer: Secondary analysis of a randomized controlled trial
Mario Lozano‐Lozano, Noelia Galiano‐Castillo, Ángela González‐Santos, et al.
Annals of Physical and Rehabilitation Medicine (2022) Vol. 66, Iss. 2, pp. 101681-101681
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top